Anti-DPP4/ DPP-4/ ADABP monoclonal antibody
Anti-DPP4/ DPP-4/ ADABP antibody for FACS & in-vivo assay
Go to DPP-4/DPP4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T31391-Ab-1/ GM-Tg-hg-T31391-Ab-2 | Anti-Human DPP-4/DPP4 monoclonal antibody | Human |
GM-Tg-rg-T31391-Ab-1/ GM-Tg-rg-T31391-Ab-2 | Anti-Rat DPP-4/DPP4 monoclonal antibody | Rat |
GM-Tg-mg-T31391-Ab-1/ GM-Tg-mg-T31391-Ab-2 | Anti-Mouse DPP-4/DPP4 monoclonal antibody | Mouse |
GM-Tg-cynog-T31391-Ab-1/ GM-Tg-cynog-T31391-Ab-2 | Anti-Cynomolgus/ Rhesus macaque DPP-4/DPP4 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T31391-Ab-1/ GM-Tg-felg-T31391-Ab-2 | Anti-Feline DPP-4/DPP4 monoclonal antibody | Feline |
GM-Tg-cang-T31391-Ab-1/ GM-Tg-cang-T31391-Ab-2 | Anti-Canine DPP-4/DPP4 monoclonal antibody | Canine |
GM-Tg-bovg-T31391-Ab-1/ GM-Tg-bovg-T31391-Ab-2 | Anti-Bovine DPP-4/DPP4 monoclonal antibody | Bovine |
GM-Tg-equg-T31391-Ab-1/ GM-Tg-equg-T31391-Ab-2 | Anti-Equine DPP-4/DPP4 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T31391-Ab-1/ GM-Tg-hg-T31391-Ab-2; GM-Tg-rg-T31391-Ab-1/ GM-Tg-rg-T31391-Ab-2; GM-Tg-mg-T31391-Ab-1/ GM-Tg-mg-T31391-Ab-2; GM-Tg-cynog-T31391-Ab-1/ GM-Tg-cynog-T31391-Ab-2; GM-Tg-felg-T31391-Ab-1/ GM-Tg-felg-T31391-Ab-2; GM-Tg-cang-T31391-Ab-1/ GM-Tg-cang-T31391-Ab-2; GM-Tg-bovg-T31391-Ab-1/ GM-Tg-bovg-T31391-Ab-2; GM-Tg-equg-T31391-Ab-1/ GM-Tg-equg-T31391-Ab-2 |
Products Name | Anti-DPP-4/DPP4 monoclonal antibody |
Format | mab |
Target Name | DPP-4 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-DPP-4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Biosimilar | GMP-Bios-ab-054 | Pre-Made Begelomab biosimilar, Whole mAb, Anti-DPP4/DPP-4 Antibody: Anti-ADABP/ADCP2/CD26/DPPIV/TP103 therapeutic antibody |
Target Antigen | Products Developing | Multi-species DPP4/ DPP-4/ ADABP VLP (virus-like particle) (Products Developing) |
Cytokine | GM-Tg-g-T31391-Ag-1 | dipeptidylpeptidase 4 (DPP4) protein |
ORF Viral Vector | pGMAAV000048 | mouse Dpp4 AAV plasmid |
ORF Viral Vector | vGMAAV000048 | mouse Dpp4 AAV particle |
Target information
Target ID | GM-T31391 |
Target Name | DPP-4 |
Gene ID | 1803,13482,25253,654491,478767,493787,281122,100061124 |
Gene Symbol and Synonyms | ACT3,ADABP,ADCP-I,ADCP2,CD26,Dpp-4,DPP4,DPPIV,THAM,TP103,WC10 |
Uniprot Accession | P27487,P14740,Q9N2I7,P81425 |
Uniprot Entry Name | DPP4_HUMAN,DPP4_RAT,DPP4_FELCA,DPP4_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
Disease | Prostate Cancer, Ureteral obstruction, Diabetic Nephropathy |
Gene Ensembl | ENSG00000197635 |
Target Classification | Checkpoint-Immuno Oncology |
The target: DPP-4, gene name: DPP4, also named as ADABP, ADCP2, CD26, DPPIV, TP103. The DPP4 gene encodes dipeptidyl peptidase 4, which is identical to adenosine deaminase complexing protein-2, and to the T-cell activation antigen CD26. It is an intrinsic type II transmembrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. Dipeptidyl peptidase 4 is highly involved in glucose and insulin metabolism, as well as in immune regulation. This protein was shown to be a functional receptor for Middle East respiratory syndrome coronavirus (MERS-CoV), and protein modeling suggests that it may play a similar role with SARS-CoV-2, the virus responsible for COVID-19. [provided by RefSeq, Apr 2020].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.